Financially Uncertain Essential Seeks To Divest Some Assets March 6, 2003 By Aaron Lorenzo No Comments
Financially Uncertain Essential Seeks To Divest Some Assets March 6, 2003 By Aaron Lorenzo No Comments
Viragen Continues Restructuring To Sustain Remaining Resources March 5, 2003 By Aaron Lorenzo No Comments
YM BioSciences Receives FDA Nod For Phase III Cancer Trial March 5, 2003 By Aaron Lorenzo No Comments
YM BioSciences Receives FDA Nod For Phase III Cancer Trial March 5, 2003 By Aaron Lorenzo No Comments
Viragen Continues Restructuring To Sustain Remaining Resources March 5, 2003 By Aaron Lorenzo No Comments
AnorMED's Fosrenol Receives Approvable Letter From FDA March 4, 2003 By Aaron Lorenzo No Comments The regulatory approval horizon appears closer than ever for the kidney disease drug Fosrenol. (BioWorld Today)Read More
AnorMED's Fosrenol Receives Approvable Letter From FDA March 4, 2003 By Aaron Lorenzo No Comments The regulatory approval horizon appears closer than ever for the kidney disease drug Fosrenol. (BioWorld Today)Read More
